NewsBenzingaノバルティス、ALS実験薬の試験を中止し、脳への薬物送達プラットフォームを取得 ノバルティス、ALS実験薬の試験を中止し、脳への薬物送達プラットフォームを取得 Benzinga 2026.09.17 16:47 (GMT+0) Open on Benzinga Other news Earnings Preview: What to Expect From Phillips 66's Report Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 6.03 Million Tokens, and Total Crypto and Total Cash & Marketable Securities Holdings of $16.2 Billion Investors Are Pushing Into Tobacco Stocks as Rate Concerns Return. What That Means for Altria. Former Plaud exec raises $26M for AI app that listens to you in the background Southwest Airlines' Q3 2026 Earnings: What to Expect ConocoPhillips Stock Has Been in a Trading Range - Ideal for Short Put COP Plays
Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 6.03 Million Tokens, and Total Crypto and Total Cash & Marketable Securities Holdings of $16.2 Billion
